Relationship Between Obesity, Menopausal Status and Breast Cancer Risks - A Review
Obesity, Menopausal Status and Breast Cancer Risks
DOI:
https://doi.org/10.54393/pjhs.v3i07.432Keywords:
Breast cancer, obesity, Risk Factors, Menopausal Status, Adipose tissue EstrogenAbstract
“Breast cancer” is of the leading malignant type of neoplasia responsible for causing high rate of mortality and morbidity. There are many risk factors of “breast cancer” but “obesity” and increased weight have been recognised as the principal risk factors as well as the prognostic factors causing “breast cancer” especially in “postmenopausal” female. “obesity” possess the complex association with “breast cancer” which varies in menopause status (“premenopausal” and “postmenopausal”) women. There are various hypotheses which have been proposed to demonstrate the interaction among “obesity” and high risks of “breast cancer” in “postmenopausal” females. The specific “obesity”-associated factors”, such as leptin, insulin, and inflammatory mediators, are also involved in influencing the progression of “breast cancer” and its prognosis independent of the estrogen level and show their effects at a cellular level by interacting with estrogen signalling pathways. The adiposity level of before the menopause, is inversely interrelated to “breast cancer” risk, exhibiting the protective effect, however in “postmenopausal” females, predominantly in elderly women, the association is positively related to cancer, indicating “obesity” as a risk factor of “breast cancer”. There is found a positive association of higher levels of estrogen production in adipose tissue, consequently resulting in elevated levels of estradiol in systematic circulation, promoting “obesity” related breast carcinogenesis in in “postmenopausal” women. The expression of tumors also effect both progesterone and estrogen receptors. It can be concluded that relation of adiposity and menopausal status is protective effect in younger females (<35 years), before the menopause and negative effects promoting the cancer in older “postmenopausal” women. Therefore, the body composition and “obesity” are highest risk factors for the prognosis of “postmenopausal” breast carcinoma.
References
Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre-and post-menopausal women: findings from the UK Biobank. British journal of cancer. 2021 Jul; 125(1): 126-34. doi: 10.1038/s41416-021-01392-z
Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocrine-related cancer. 2005 Dec; 12(4): 1071-82. doi: 10.1677/erc.1.01038
Rinaldi S, Key TJ, Peeters PH, Lahmann PH, Lukanova A, Dossus L, et al. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. International journal of cancer. 2006 Jun; 118(11): 2832-9. doi: 10.1002/ijc.21730
Rose DP, Vona-Davis L. Influence of obesity on breast cancer receptor status and prognosis. Expert review of anticancer therapy. 2009 Aug; 9(8): 1091-101. doi: 10.1586/era.09.71
Nindrea RD, Aryandono T, Lazuardi L, Dwiprahasto I. Association of overweight and obesity with breast cancer during premenopausal period in Asia: A meta-analysis. International Journal of Preventive Medicine. 2019; 10: 192-196. doi: 10.4103/ijpvm.IJPVM_372_18
Vona‐Davis L, Howard‐McNatt M, Rose DP. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obesity Reviews. 2007 Sep; 8(5): 395-408. doi: 10.1111/j.1467-789X.2007.00396.x
Brown KA, Simpson ER. Obesity and breast cancer: progress to understanding the relationship. Cancer research. 2010 Jan; 70(1): 4-7. doi: 10.1158/0008-5472.CAN-09-2257
García-Estévez L, Cortés J, Pérez S, Calvo I, Gallegos I, Moreno-Bueno G. Obesity and breast cancer: a paradoxical and controversial relationship influenced by menopausal status. Frontiers in Oncology. 2021 Aug; 11: 705911.doi: 10.3389/fonc.2021.705911
Van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. American journal of epidemiology. 2000 Sep; 152(6): 514-27. doi: 10.1093/aje/152.6.514
Howell A, Chapman M, Harvie M. Energy restriction for breast cancer prevention. Cancer Prevention II. 2009; 181: 97-111. doi: 10.1007/978-3-540-69297-3_11
Khalis M, Dossus L, Rinaldi S, Biessy C, Moskal A, Charaka H, et al. Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case–control study. Breast Cancer. 2020 Jul; 27(4): 748-58. doi: 10.1007/s12282-020-01072-5
Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, et al. Waist circumference, waist: hip ratio, and risk of breast cancer in the Nurses' Health Study. American journal of epidemiology. 1999 Dec; 150(12): 1316-24. doi: 10.1093/oxfordjournals.aje.a009963
McTiernan A, Rajan B, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2003 May; 21(10): 1961-66. doi: 10.1200/JCO.2003.07.057
Baglietto L, English DR, Hopper JL, MacInnis RJ, Morris HA, Tilley WD, et al. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast cancer research and treatment. 2009 May; 115(1): 171-9. doi: 10.1007/s10549-008-0069-3
Harini M. A Study on Correlation between Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor-2 Status and Other Prognostic Factors in Carcinoma Breast (Doctoral dissertation, Madras Medical College, Chennai). 2019.
Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutrition and cancer. 2003 Jan; 45(1): 1-16. doi: 10.1207/S15327914NC4501_1
Johnson NA, Ho A, Cline JM, Hughes CL, Foster WG, Davis VL. Accelerated mammary tumor onset in a HER2/Neu mouse model exposed to DDT metabolites locally delivered to the mammary gland. Environmental health perspectives. 2012 Aug; 120(8): 1170-6. doi: 10.1289/ehp.1104327
Dal Bello PP, Coelho CC, Rapatoni L, Peria FM. Relationship between obesity and breast câncer. Mastology (Impr.). 2018; 28(1): 46-50. 10.29289/Z2594539420180000196
Peacock SL, White E, Daling JR, Voigt LF, Malone KE. Relation between obesity and breast cancer in young women. American journal of epidemiology. 1999 Feb; 149(4): 339-46. doi: 10.1093/oxfordjournals.aje.a009818
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. Bmj. 2007 Nov; 335(7630): 1134. doi: 10.1136/bmj.39367.495995.AE
Lahmann PH, Hoffmann K, Allen N, Van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). International journal of cancer. 2004 Sep; 111(5): 762-71. doi: 10.1002/ijc.20315
Brantley KD, Zeleznik OA, Dickerman BA, Balasubramanian R, Clish CB, Avila-Pacheco J, et al. A metabolomic analysis of adiposity measures and pre-and postmenopausal breast cancer risk in the Nurses’ Health Studies. British Journal of Cancer. 2022 Oct; 127(6): 1076-85. doi: 10.1038/s41416-022-01873-9
Emaus A, Espetvedt S, Veierød MB, Ballard-Barbash R, Furberg AS, Ellison PT, et al. 17-β-estradiol in relation to age at menarche and adult obesity in premenopausal women. Human reproduction. 2008 Apr; 23(4): 919-27. doi: 10.1093/humrep/dem432
Sturgeon SR, Potischman N, Malone KE, Dorgan JF, Daling J, Schairer C, et al. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case–control study (USA). Cancer Causes & Control. 2004 Feb; 15(1): 45-53. doi: 10.1023/B: CACO.0000016574.79728.11
Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. Journal of the National Cancer Institute. 2006 Oct; 98(19): 1406-15. doi: 10.1093/jnci/djj376
Zain MM and Norman RJ. Impact of obesity on female fertility and fertility treatment. Women’s health. 2008 Mar; 4(2): 183-94. doi: 10.2217/17455057.4.2.183
Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta‐analysis. International journal of cancer. 2009 Feb; 124(3): 698-712. doi: 10.1002/ijc.23943
Terry KL, Willett WC, Rich-Edwards JW, Michels KB. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Archives of internal medicine. 2006 Dec; 166(22): 2484-9. doi: 10.1001/archinte.166.22.2484
Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Archives of internal medicine. 2006 Nov; 166(21): 2395-402. doi: 10.1001/archinte.166.21.2395
Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. International journal of cancer. 2001 Feb; 91(3): 421-30. doi: 10.1002/1097-0215(200002)9999: 9999%3C: : AID-IJC1053%3E3.0.CO; 2-T
Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, et al. A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer epidemiology, biomarkers & prevention. 2010 Jun; 19(6): 1532-44. doi: 10.1158/1055-9965.EPI-10-0025
Harris HR, Willett WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses’ Health Study II. Journal of the National Cancer Institute. 2011 Feb; 103(3): 273-8. doi: 10.1093/jnci/djq500
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The lancet. 2008 Feb; 371(9612): 569-78. doi: 10.1016/S0140-6736(08)60269-X
Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O’Brien KM, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA oncology. 2018 Nov 1; 4(11): e181771. doi: 10.1001/jamaoncol.2018.1771
Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, et al. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiology Biomarkers & Prevention. 2006 Dec; 15(12): 2482-8. doi: 10.1158/1055-9965.EPI-06-0489
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. Bmj. 2007 Nov; 335(7630): 1134. doi: 10.1136/bmj.39367.495995.AE
Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA oncology. 2015 Aug; 1(5): 611-21. doi: 10.1001/jamaoncol.2015.1546
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
